Browsing: Drug
Fotolia/iStock by way of Getty Pictures JPMorgan just lately raised its projections for weight reduction medication, anticipating the drug class…
juststock Mizuho downgraded BioXcel Therapeutics (NASDAQ:BTAI) to impartial and slashed its worth goal within the wake of the corporate’s Q2…
zimmytws Leqembi, the brand new Alzheimer’s remedy developed by Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY), might add $2B – $5B…
Wirestock The United Nations-backed Medicines Patent Pool (MPP) signed agreements with Aurobindo, Cipla and Viatris (NASDAQ:VTRS) to provide generic variations…
koto_feja Eli Lilly (NYSE:LLY) shared information from a Part 3 trial for its Alzheimer’s illness donanemab, evaluating its efficiency in…
Olivier Le Moal/iStock through Getty Photos A rise within the affected person inhabitants mixed with new therapies in growth implies…
Roland Magnusson/iStock Editorial through Getty Photographs South Korea’s Truthful Commerce Fee (FTC) fined AstraZeneca (NASDAQ:AZN) and Alvogen 2.6B Korean gained…
Dave Kotinsky/Getty Pictures Leisure Proposed drug pricing laws from Senate Democrats, if handed, would have an effect on income for…